Real Time PCR Detection of Minimal Residual Disease in Patients with Neuroblastoma

被引：0
|
作者：
Brilliantova, V. [1 ]
Shevtsov, D. [1 ]
Shamanskaya, T. [1 ]
Drui, A. [1 ]
Kachanov, D. [1 ]
Stepovik, E. [1 ]
Raykina, E. [1 ]
机构：
[1] Russian Minist Hlth, Dmytry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-327
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [1] Application of molecular markers for minimal residual disease detection in neuroblastoma using real-time PCR technology.
    Zhou, JB
    Li, AH
    Diller, L
    Gribben, JG
    BLOOD, 2003, 102 (11) : 215B - 216B
  • [2] Detection of minimal residual disease in high-risk neuroblastoma patients by digital PCR
    Nishimura, Noriyuki
    Ishida, Toshiaki
    Uemura, Suguru
    Yamamoto, Nobuyuki
    Hasegawa, Daiichiro
    CANCER SCIENCE, 2018, 109 : 1113 - 1113
  • [3] Detection and monitoring of minimal residual disease by quantitative real-time PCR
    Schüler, F
    Dölken, G
    CLINICA CHIMICA ACTA, 2006, 363 (1-2) : 147 - 156
  • [4] Detection of minimal residual disease and assessment of stem cell purging by TaqMan real time PCR quantitation of GAGE expression in patients with neuroblastoma.
    Ash, S
    Donovan, JW
    Temel, J
    Zuckerman, A
    Grupp, SD
    Diller, L
    Gribben, JG
    BLOOD, 2000, 96 (11) : 187A - 187A
  • [5] Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma
    Ifversen, MRS
    Kågedal, B
    Christensen, LD
    Rechnitzer, C
    Petersen, BL
    Heilmann, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (01) : 121 - 129
  • [6] Detecting Minimal Residual Disease in Neuroblastoma: The Superiority of a Panel of Real-Time Quantitative PCR Markers
    Stutterheim, Janine
    Gerritsen, Annemieke
    Zappeij-Kannegieter, Lily
    Yalcin, Bilgehan
    Dee, Rob
    van Noesel, Max M.
    Berthold, Frank
    Versteeg, Rogier
    Caron, Huib N.
    van der Schoot, C. Ellen
    Tytgat, Godelieve A. M.
    CLINICAL CHEMISTRY, 2009, 55 (07) : 1316 - 1326
  • [7] Prognostic impact and detection of minimal residual disease (MRD) in neuroblastoma patients
    Druy, Alexander
    Tsaur, Grigory
    Popov, Alexander
    Verzhbitskaya, Tatiana
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma
    Stutterheim, Janine
    Zappeij-Kannegieter, Lily
    Ora, Ingrid
    van Sluis, Peter G.
    Bras, Johannes
    den Ouden, Emmy
    Versteeg, Rogier
    Caron, Huib N.
    van der Schoot, C. Ellen
    Tytgat, Godelieve A. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (02): : 168 - 175
  • [9] Minimal residual disease detection in acute lymphoblastic leukemia: Real improvement with the real-time quantitative PCR method?
    Neale, GAM
    Campana, D
    Pui, CH
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (02) : 100 - 102
  • [10] Dynamics of Minimal Residual Disease in Neuroblastoma Patients
    Uemura, Suguru
    Ishida, Toshiaki
    Thwin, Khin Kyae Mon
    Yamamoto, Nobuyuki
    Tamura, Akihiro
    Kishimoto, Kenji
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    Nino, Nanako
    Lin, Kyaw San
    Takafuji, Satoru
    Mori, Takeshi
    Iijima, Kazumoto
    Nishimura, Noriyuki
    FRONTIERS IN ONCOLOGY, 2019, 9
12345